Results 71 to 80 of about 87,371,428 (168)

Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail

, 2022
Introduction: Correctional officials often cite diversion of medication for opioid use disorder (MOUD) treatment (e.g., buprenorphine) as a reason for not offering MOUD treatment in jails and prisons, but it is poorly understood whether these fears are ...
Friedmann, Peter, MD, Ekaterina Pivovarova, Elizabeth A. Evans, Thomas J. Stopka, Peter D. Friedmann, Warren J. Ferguson, Claudia Santelices   +6 more
core   +1 more source

Research letter: Association of duration of methadone or buprenorphine use during pregnancy with risk of nonfatal drug overdose among pregnant persons with opioid use disorder in the US.

, 2022
Opioid use disorder (OUD) is associated with morbidity and mortality during pregnancy and post partum, and emerging evidence suggests that drug-related deaths are a leading cause of mortality.
Chen, Qingwen, Gao, Alice, Rothenberger, Scott D, Krans, Elizabeth E, Jarlenski, Marian   +4 more
core   +1 more source

What Tools Do We Have to End the US HIV Epidemic? A Review of Structural, Biomedical and Implementation Interventions and Their Potential Population Impact

Journal of the International AIDS Society, Volume 29, Issue 7, July 2026.
ABSTRACT Introduction The United States Ending the HIV Epidemic (EHE) initiative was always challenged by structural and implementation barriers to HIV care. On top of that, since 2025, there are additional political and policy barriers that make this goal seem increasingly difficult to achieve.
Micah Piske, Brenda Carolina Guerra‐Alejos, Minh Tri Van, Benjamin Enns, Melanie G. Medina, Xiao Zang, Wendy S. Armstrong, Czarina Behrends, Carlos del Rio, Eva Enns, Elvin H. Geng, Matthew R. Golden, Brandon D. L. Marshall, Shruti H. Mehta, Lisa R. Metsch, Bruce R. Schackman, Steffanie A. Strathdee, Hansel E. Tookes, Bohdan Nosyk, the Localized Economic Modeling group   +19 more
wiley   +1 more source

Opioid overdose after medication for opioid use disorder initiation following hospitalization or ED visit.

Importance: Hospitalizations related to opioid use disorder (OUD) represent an opportunity to initiate medication for OUD (MOUD). Question: Is starting medication for opioid use disorder (OUD) treatment after a hospital visit associated with lower ...
Weiner, Scott G, Wright, Dagan A, Ritter, Grant A, Hildebran, Christi, El Ibrahimi, Sanae, Little, Kacey, Yoo, Jiah, Flores, Diana P   +7 more
core   +1 more source

Association between Prescribers’ Perceptions of the Utilization of Medication for Opioid Use Disorder and Opioid Dependence Treatability

, 2022
Background: Medication for opioid use disorder (MOUD) has been proven to be effective, yet the perceptions or beliefs of prescribers of MOUD may have a substantial impact on their prescribing and dispensing of MOUD and their patients’ accessibility
Wilkerson, J. Michael, Angela Di Paola, Zhu, Jialing, Adzrago, David, Jialing Zhu, David Adzrago, Alejandro Betancur, Betancur, Alejandro, J. Michael Wilkerson, Paola, Angela Di   +9 more
core   +1 more source

Influence of residential greenness and season on discontinuation of medication treatment for opioid use disorder across rural to urban community types

Addictive Behaviors Reports
Introduction: Medications for opioid use disorder (MOUD) are standard of care for opioid use disorder (OUD), but high rates of treatment discontinuation limit their impact on recovery.
Melissa N. Poulsen, Cara M. Nordberg, Karen Bandeen-Roche, Joseph DeWalle, Wade Berrettini, Brian S. Schwartz   +5 more
doaj   +1 more source

Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system [PDF]

, 2019
In 2013, Vermont leaders implemented the "hub-and-spoke" (H & S) system to increase access to medication treatment for opioid use disorder (MOUD).
Cousins, Sarah, Pearce, Regina, McCann, Michael, Rieckmann, Traci, Rawson, Richard A   +4 more
core   +1 more source

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice
Background Hospitalizations involving opioid use disorder (OUD) are increasing. Addiction consultation services (ACS) initiate medications for opioid use disorder (MOUD) in hospital settings and arrange post-hospital follow-up for ongoing MOUD care ...
Gavin Bart, Kelly S. Barth, Paulette Baukol, Eva Enns, Udi E. Ghitza, Jacklyn Harris, Eve Jelstrom, Jane M. Liebschutz, Kara M. Magane, Delia Voronca, Zoe M. Weinstein, P. Todd Korthuis   +11 more
doaj   +1 more source

Identifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach.

PLoS ONE
IntroductionOpioid overdose is a major public health challenge. We aimed to understand facilitators and barriers to engagement in medication for opioid use disorder (MOUD) among persons with OUD in Washington, DC.MethodsWe used a cross-sectional mixed ...
Britta Gullahorn, Irene Kuo, Artius M Robinson, Johnny Bailey, Jennifer Loken, Tamara Taggart   +5 more
doaj   +1 more source

Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts

, 2023
Background: Carceral officials often cite diversion of medication for opioid use disorder (MOUD) (e.g., buprenorphine) as a reason for not offering MOUD treatment in jails and prisons with little understanding of patient perspectives.
Friedmann, Peter, MD
core   +1 more source